The Alzheimer's Disease Neuroimaging Initiative (ADNI) is a multisite, longitudinal study that assesses clinical, imaging, genetic, and biospecimen biomarkers through the process of normal aging to mild cognitive impairment and dementia. We present the creation of the Argentina‐ADNI—the first South American ADNI—and its effort to acquire data comparable with those gathered in other worldwide ADNI centers.